Early research (Phase 1)Ended earlyNCT03277209
What this trial is testing
To Assess the Safety of Continuous IV Administration of Plerixafor and Assess Impact on the Immune Microenvironment in Patients With Pancreatic, Ovarian and Colorectal Adenocarcinomas
Who this might be right for
Pancreas Cancer
Weill Medical College of Cornell University 2